In graphics: Will South Africa meet UNAIDS’s HIV targets for 2020?
Is South Africa on course to meet UNAIDS’s HIV targets set for 2020? These four graphs track our progress.
Caveat emptor: Seven things every patient should know about switching from efavirenz to dolutegravir
A new antiretroviral medicine called dolutegravir is about to be introduced in the public healthcare system. Dr Tom Boyles outlines seven things people may want to consider before switching to the new drug.
Modernising ART
By Dr Michelle Moorhouse – Antiretroviral therapy (ART) in South Africa seems set for a revolution with a new drug combination that is highly effective and involves only one pill a day that is smaller than an aspirin. One of South Africa’s top HIV clinicians explains.
How HIV shaped us
By Professor Glenda Gray & Professor James A. McIntyre – HIV changed the nature of health in South Africa as our new democracy emerged. Seemingly overnight, in front of our eyes, young people and children died in unprecedented numbers. HIV slashed life expectancy, wiped out a generation of economically active adults in their prime across sub-Saharan Africa, reversed gains in under-five mortality and created a cohort of AIDS orphans.
HIV and non-communicable diseases: a dangerous partnership
Over the years, HIV and the ensuing global epidemic has resulted in millions of deaths. With the advent of antiretroviral therapy, and the advocacy efforts of civil society, HIV-related mortality has significantly decreased, as has mother-to-child transmission.